195 related articles for article (PubMed ID: 36723429)
21. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function.
Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP
FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of the CT GalNAc transferase inhibits muscular dystrophy in a cleavage-resistant dystroglycan mutant mouse.
Jayasinha V; Hoyte K; Xia B; Martin PT
Biochem Biophys Res Commun; 2003 Mar; 302(4):831-6. PubMed ID: 12646245
[TBL] [Abstract][Full Text] [Related]
23. 3D structural analysis of protein O-mannosyl kinase, POMK, a causative gene product of dystroglycanopathy.
Nagae M; Mishra SK; Neyazaki M; Oi R; Ikeda A; Matsugaki N; Akashi S; Manya H; Mizuno M; Yagi H; Kato K; Senda T; Endo T; Nogi T; Yamaguchi Y
Genes Cells; 2017 Apr; 22(4):348-359. PubMed ID: 28251761
[TBL] [Abstract][Full Text] [Related]
24. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
Yoshida-Moriguchi T; Willer T; Anderson ME; Venzke D; Whyte T; Muntoni F; Lee H; Nelson SF; Yu L; Campbell KP
Science; 2013 Aug; 341(6148):896-9. PubMed ID: 23929950
[TBL] [Abstract][Full Text] [Related]
25. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
[TBL] [Abstract][Full Text] [Related]
26. Lassa Fever Virus Binds Matriglycan-A Polymer of Alternating Xylose and Glucuronate-On α-Dystroglycan.
Joseph S; Campbell KP
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578260
[TBL] [Abstract][Full Text] [Related]
27. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
[TBL] [Abstract][Full Text] [Related]
28. Hypoglycosylation of dystroglycan due to T192M mutation: a molecular insight behind the fact.
Bhattacharya S; Das A; Ghosh S; Dasgupta R; Bagchi A
Gene; 2014 Mar; 537(1):108-14. PubMed ID: 24361964
[TBL] [Abstract][Full Text] [Related]
29. Identification of a short, single site matriglycan that maintains neuromuscular function in the mouse.
Yang T; Chandel I; Gonzales M; Okuma H; Prouty SJ; Zarei S; Joseph S; Garringer KW; Landa SO; Yonekawa T; Walimbe AS; Venzke DP; Anderson ME; Hord JM; Campbell KP
bioRxiv; 2023 Dec; ():. PubMed ID: 38187633
[TBL] [Abstract][Full Text] [Related]
30. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
[TBL] [Abstract][Full Text] [Related]
31. An atypical expression of core α-Dystroglycan and Laminin-α2 in skin fibroblasts of patients with congenital muscular dystrophies.
Sabry S; Issa MY; Abdel-Hamid MS; Eissa NR; Abdel-Ghafar SF; Ibrahim MM; Zaki MS
Mol Biol Rep; 2023 Aug; 50(8):6373-6379. PubMed ID: 37318662
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for matriglycan synthesis by the LARGE1 dual glycosyltransferase.
Katz M; Diskin R
PLoS One; 2022; 17(12):e0278713. PubMed ID: 36512577
[TBL] [Abstract][Full Text] [Related]
33. Structural basis of laminin binding to the LARGE glycans on dystroglycan.
Briggs DC; Yoshida-Moriguchi T; Zheng T; Venzke D; Anderson ME; Strazzulli A; Moracci M; Yu L; Hohenester E; Campbell KP
Nat Chem Biol; 2016 Oct; 12(10):810-4. PubMed ID: 27526028
[TBL] [Abstract][Full Text] [Related]
34. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
[TBL] [Abstract][Full Text] [Related]
35. The underlying mechanisms of arenaviral entry through matriglycan.
Katz M; Diskin R
Front Mol Biosci; 2024; 11():1371551. PubMed ID: 38516183
[TBL] [Abstract][Full Text] [Related]
36. LARGE expression augments the glycosylation of glycoproteins in addition to α-dystroglycan conferring laminin binding.
Zhang Z; Zhang P; Hu H
PLoS One; 2011 Apr; 6(4):e19080. PubMed ID: 21533062
[TBL] [Abstract][Full Text] [Related]
37. Dystroglycan glycosylation and muscular dystrophy.
Moore CJ; Hewitt JE
Glycoconj J; 2009 Apr; 26(3):349-57. PubMed ID: 18773291
[TBL] [Abstract][Full Text] [Related]
38. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.
Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L
Elife; 2016 Apr; 5():. PubMed ID: 27130732
[TBL] [Abstract][Full Text] [Related]
39. α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.
Palmieri V; Bozzi M; Signorino G; Papi M; De Spirito M; Brancaccio A; Maulucci G; Sciandra F
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2182-2191. PubMed ID: 28572004
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
